share

5,6-Dihydro-9-Methoxy-4-Methyl-1-Phenyl-4H-[1,2,4]Triazolo[4,3-A][1,5]Benzodiazepine CAS NO 54028-95-4


Unit Price:

CAS No.:54028-95-4

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

5,6-Dihydro-9-Methoxy-4-Methyl-1-Phenyl-4H-[1,2,4]Triazolo[4,3-A][1,5]Benzodiazepine is a high-purity, complex heterocyclic compound belonging to the benzodiazepine class, serving as a critical pharmaceutical intermediate and research chemical. Its intricate fused-ring structure makes it a valuable building block for the synthesis of novel active pharmaceutical ingredients (APIs) and for advanced pharmacological studies. This compound is primarily sought by pharmaceutical R&D laboratories, contract research organizations (CROs), and fine chemical manufacturers engaged in developing new therapeutic agents.

Application

  • Pharmaceutical Intermediate: Key synthetic precursor in the research and development of novel benzodiazepine-derived therapeutic agents.
  • Active Pharmaceutical Ingredient (API) Research: Used as a core scaffold for structure-activity relationship (SAR) studies in medicinal chemistry.
  • Neurological & Psychiatric Drug Discovery: Investigated for potential applications in targeting central nervous system (CNS) receptors.
  • Reference Standard: Serves as a high-purity analytical standard for quality control and method development in pharmaceutical analysis.
  • Biochemical Research: Utilized in vitro studies to investigate ligand-receptor interactions and biochemical pathways.
  • Academic Research: Employed in university and institutional labs for advanced organic synthesis and heterocyclic chemistry studies.

Basic Information

Product Name 5,6-Dihydro-9-Methoxy-4-Methyl-1-Phenyl-4H-[1,2,4]Triazolo[4,3-A][1,5]Benzodiazepine
CAS No. 54028-95-4
Molecular Formula C19H18N4O
Molecular Weight 318.38 g/mol
Synonyms 9-Methoxy-4-methyl-1-phenyl-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepine; 4H-[1,2,4]Triazolo[4,3-a][1,5]benzodiazepine, 5,6-dihydro-9-methoxy-4-methyl-1-phenyl-; 54028-95-4; Triazolobenzodiazepine derivative; Methoxy-methyl-phenyl-triazolobenzodiazepine
EINECS Contact for details

Quality Control

Our 5,6-Dihydro-9-Methoxy-4-Methyl-1-Phenyl-4H-[1,2,4]Triazolo[4,3-A][1,5]Benzodiazepine is manufactured under strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the exacting standards required for pharmaceutical research. Certificates of Analysis (COA) with detailed chromatographic data are provided to guarantee traceability and batch-to-batch consistency.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider conditions under an inert atmosphere to ensure optimal stability.

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference standard
Purity (HPLC) ≥ 98.0%
Related Substances (HPLC) Total impurities ≤ 2.0%
Loss on Drying ≤ 0.5%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.